X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
Australia
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
0
https://www.business-standard.com/markets/capital-market-news/dr-reddy-s-labs-partners-with-bayer-for-second-brand-of-vericiguat-for-india-market-124040600101_1.html
https://www.clinicaltrialsarena.com/news/merck-trial-verquvo-heart-failure/
https://www.ema.europa.eu/en/documents/overview/verquvo-epar-medicine-overview_en.pdf
https://www.biopharmadive.com/news/merck-bayer-win-fda-approval-for-heart-failure-drug/593659/
http://www.pharmatimes.com/news/us_approval_for_msds_heart_failure_med_verquvo_1361684
https://www.fiercepharma.com/pharma/merck-bayer-win-fda-nod-for-verquvo-even-more-competitive-heart-failure-field
https://pharmashots.com/press-releases/bayer-submits-vericiguat-for-marketing-authorization-in-china-for-the-treatment-of-chronic-heart-failure/
https://www.fiercebiotech.com/biotech/fda-puts-merck-s-heart-failure-drug-priority-review-track
https://pipelinereview.com/index.php/2020060574881/Small-Molecules/Bayer-submits-vericiguat-for-marketing-authorization-in-the-EU-and-Japan-for-the-treatment-of-chronic-heart-failure.html
Market Place
Share 
